Bioinformatics and immunoinformatics to support COVID-19 vaccine development.
J Med Virol
; 93(9): 5209-5211, 2021 Sep.
Article
in English
| MEDLINE | ID: covidwho-1182167
ABSTRACT
Severe acute respiratory syndrome coronavirus 2 has infected over 109 000 000 people with 2 423 443 deaths as of February 17, 2021. Currently, there are no approved or consistently effective treatments, and conventional vaccines may take several years for development and testing. In silico methods of bioinformatics, vaccinogenomics, immunoinformatics, structural biology, and molecular simulations can be used for more rapid and precise vaccine design. This paper highlights two major immunoinformatics strategies that are used in designing novel and effective vaccines and therapeutics reverse vaccinology and structural vaccinology.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Computational Biology
/
Vaccinology
/
COVID-19 Vaccines
/
COVID-19
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
J Med Virol
Year:
2021
Document Type:
Article
Affiliation country:
Jmv.27017
Similar
MEDLINE
...
LILACS
LIS